Skip to main content
Erschienen in:

06.11.2019 | Original Article

Overactive bladder symptoms in patients undergoing rigid and flexible cystoscopy

verfasst von: Zana Saratlija Novakovic, Livia Puljak, Damir Sapunar, Mesut Remzi, Harun Fajkovic, Irene Resch, Mohammad Abufaraj, Claus Riedl, Paul Engelhardt, Wilhelm Hübner, Eckart Breinl, Mario Duvnjak, Stephan Seklehner

Erschienen in: World Journal of Urology | Ausgabe 8/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate overactive bladder (OAB) symptoms in patients undergoing diagnostic cystoscopy. Overall changes in the entire study population were assessed, as well as broken down by various subgroups.

Methods

A prospective multi-center study among consecutive 450 adults undergoing diagnostic cystoscopy was conducted. OAB-symptoms were evaluated with the validated eight-item OAB Screening Awareness Tool (OAB-V8) immediately before and on days 1, 4, and 7 after cystoscopy. Patients were distinguished between being OAB-negative and OAB-positive (< 8 and ≥ 8 sum-score, respectively). Average sum-scores and subdomains were evaluated.

Results

Before cystoscopy, 44.7% of patients were screened OAB-positive and 55.3% OAB-negative. Out of those being screened negative, development of de-novo OAB was noticed in 16.8%, declining to 8.1% on day 7 (p < 0.001).
In patients being OAB-positive before cystoscopy, a decline of OAB-positivity was noted during follow-up (p < 0.001). No statistically significant differences were noted when broken down by gender (p = 0.92), age (p = 0.82) and type cystoscope (rigid vs. flexible, p = 0.38). Average sum-scores declined from 8.68 before cystoscopy to 6.9 during follow-up. Flexible cystoscopy was superior over rigid in four subdomains: uncomfortable urge to urinate (p = 0.04), sudden urge to urinate with little or no warning (p = 0.02), uncontrollable urge to urinate (p = 0.03), and urine loss associated with a strong desire to void (p = 0.009).

Conclusion

OAB-symptoms are common in patients undergoing cystoscopy. Cystoscopy itself can cause de-novo OAB-symptoms. Controversially, a decline of OAB-symptoms was noted after cystoscopy when patients were screened OAB-positive before cystoscopy. Flexible scopes were superior in some subdomains.
Literatur
2.
Zurück zum Zitat Seklehner S, Remzi M, Fajkovic H, Saratlija-Novakovic Z, Skopek M, Resch I, Duvnjak M, Hruby S, Librenjak D, Hubner W, Breinl E, Riedl C, Engelhardt PF (2015) Prospective multi-institutional study analyzing pain perception of flexible and rigid cystoscopy in men. Urology 85:737–741CrossRef Seklehner S, Remzi M, Fajkovic H, Saratlija-Novakovic Z, Skopek M, Resch I, Duvnjak M, Hruby S, Librenjak D, Hubner W, Breinl E, Riedl C, Engelhardt PF (2015) Prospective multi-institutional study analyzing pain perception of flexible and rigid cystoscopy in men. Urology 85:737–741CrossRef
3.
Zurück zum Zitat Seklehner S, Saratlija-Novakovic Z, Skopek M, Fajkovic H, Remzi M, Duvnjak M, Resch I, Hruby S, Lm HW, Librenjak D, Breinl E, Riedl C, Engelhardt PF (2016) Prospective, multi-institutional pain assessment of 150 women undergoing diagnostic cystoscopy. Minerva Urol Nefrol 68:417–423PubMed Seklehner S, Saratlija-Novakovic Z, Skopek M, Fajkovic H, Remzi M, Duvnjak M, Resch I, Hruby S, Lm HW, Librenjak D, Breinl E, Riedl C, Engelhardt PF (2016) Prospective, multi-institutional pain assessment of 150 women undergoing diagnostic cystoscopy. Minerva Urol Nefrol 68:417–423PubMed
4.
Zurück zum Zitat Erkal S (2007) Patients' experiences at home after day case cystoscopy. J Clin Nurs 16:1118–1124CrossRef Erkal S (2007) Patients' experiences at home after day case cystoscopy. J Clin Nurs 16:1118–1124CrossRef
5.
Zurück zum Zitat Drake MJ (2014) Do we need a new definition of the overactive bladder syndrome? ICI-RS 2013. Neurourol Urodyn 33:622–624CrossRef Drake MJ (2014) Do we need a new definition of the overactive bladder syndrome? ICI-RS 2013. Neurourol Urodyn 33:622–624CrossRef
6.
Zurück zum Zitat Coyne KS, Zyczynski T, Margolis MK, Elinoff V, Roberts RG (2005) Validation of an overactive bladder awareness tool for use in primary care settings. Adv Ther 22:381–394CrossRef Coyne KS, Zyczynski T, Margolis MK, Elinoff V, Roberts RG (2005) Validation of an overactive bladder awareness tool for use in primary care settings. Adv Ther 22:381–394CrossRef
8.
Zurück zum Zitat Cheung WW, Blank W, Borawski D, Tran W, Bluth MH (2010) Prevalence of overactive bladder, its under-diagnosis, and risk factors in a male urologic veterans population. Int J Med Sci 7:391–394CrossRef Cheung WW, Blank W, Borawski D, Tran W, Bluth MH (2010) Prevalence of overactive bladder, its under-diagnosis, and risk factors in a male urologic veterans population. Int J Med Sci 7:391–394CrossRef
9.
Zurück zum Zitat Cheung WW, Khan NH, Choi KK, Bluth MH, Vincent MT (2009) Prevalence, evaluation and management of overactive bladder in primary care. BMC Fam Pract 10:8CrossRef Cheung WW, Khan NH, Choi KK, Bluth MH, Vincent MT (2009) Prevalence, evaluation and management of overactive bladder in primary care. BMC Fam Pract 10:8CrossRef
10.
Zurück zum Zitat Casteleijn NF, Vriesema JL, Stomps SP, Van Balen OL, Cornel EB (2017) The effect of office based flexible and rigid cystoscopy on pain experience in female patients. Investig Clin Urol 58:48–53CrossRef Casteleijn NF, Vriesema JL, Stomps SP, Van Balen OL, Cornel EB (2017) The effect of office based flexible and rigid cystoscopy on pain experience in female patients. Investig Clin Urol 58:48–53CrossRef
11.
Zurück zum Zitat Gee JR, Waterman BJ, Jarrard DF, Hedican SP, Bruskewitz RC, Nakada SY (2009) Flexible and rigid cystoscopy in women. JSLS 13:135–138PubMedPubMedCentral Gee JR, Waterman BJ, Jarrard DF, Hedican SP, Bruskewitz RC, Nakada SY (2009) Flexible and rigid cystoscopy in women. JSLS 13:135–138PubMedPubMedCentral
12.
Zurück zum Zitat Krajewski W, Zdrojowy R, Wojciechowska J, Koscielska K, Dembowski J, Matuszewski M, Tupikowski K, Malkiewicz B, Kolodziej A (2016) Patient comfort during flexible and rigid cystourethroscopy. Wideochir Inne Tech Maloinwazyjne 11:94–97PubMedPubMedCentral Krajewski W, Zdrojowy R, Wojciechowska J, Koscielska K, Dembowski J, Matuszewski M, Tupikowski K, Malkiewicz B, Kolodziej A (2016) Patient comfort during flexible and rigid cystourethroscopy. Wideochir Inne Tech Maloinwazyjne 11:94–97PubMedPubMedCentral
13.
Zurück zum Zitat Clayman RV, Reddy P, Lange PH (1984) Flexible fiberoptic and rigid-rod lens endoscopy of the lower urinary tract: a prospective controlled comparison. J Urol 131:715–716CrossRef Clayman RV, Reddy P, Lange PH (1984) Flexible fiberoptic and rigid-rod lens endoscopy of the lower urinary tract: a prospective controlled comparison. J Urol 131:715–716CrossRef
14.
Zurück zum Zitat Walker L, Liston TG, Lloyddavies RW (1993) Does flexible cystoscopy miss more tumors than rod-lens examination. Br J Urol 72:449–450CrossRef Walker L, Liston TG, Lloyddavies RW (1993) Does flexible cystoscopy miss more tumors than rod-lens examination. Br J Urol 72:449–450CrossRef
Metadaten
Titel
Overactive bladder symptoms in patients undergoing rigid and flexible cystoscopy
verfasst von
Zana Saratlija Novakovic
Livia Puljak
Damir Sapunar
Mesut Remzi
Harun Fajkovic
Irene Resch
Mohammad Abufaraj
Claus Riedl
Paul Engelhardt
Wilhelm Hübner
Eckart Breinl
Mario Duvnjak
Stephan Seklehner
Publikationsdatum
06.11.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 8/2020
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-019-02993-3

Neu im Fachgebiet Urologie

Adjuvanter PD-L1-Hemmer verhindert Rezidive bei Hochrisiko-Urothelkarzinom

Sind Menschen mit muskelinvasivem Urothelkarzinom für die neoadjuvante platinbasierte Therapie nicht geeignet oder sprechen sie darauf nicht gut an, ist Pembrolizumab eine adjuvante Alternative: Die krankheitsfreie Lebenszeit wird dadurch mehr als verdoppelt.

Nierenzellkarzinom: Kein Nachteil durch subkutan appliziertes Nivolumab

Die subkutane Applikation von Nivolumab ist nach Daten einer Phase-3-Studie ähnlich gut wirksam wie die intravenöse: Die Pharmakokinetik ist vergleichbar, die objektive Response war in der Studie sogar leicht besser als in der Gruppe mit Infusionen.

Auf weichem Fahrradsattel ist nicht gut Kinder zeugen

Männer, die sich gern sportlich verausgaben, riskieren möglicherweise, fürs Vaterwerden nicht genug Kräfte übrig zu haben. In einer Studie fanden sich dafür zwar allenfalls schwache Anzeichen. Es gab jedoch eine Ausnahme.

Vorteile für Androgenentzug plus Androgenrezeptorblockade

Für Männer mit metastasiertem hormonsensitivem Prostata-Ca. (mHSPC), die keine Hormonchemotherapie wollen oder vertragen, ist der Androgenentzug plus Darolutamid eine Alternative: Das Progressionsrisiko wird im Vergleich zum alleinigen Androgenentzug fast halbiert.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.